FL S1404 | 2018 | Regular Session

Status

Completed Legislative Action
Spectrum: Partisan Bill (Republican 1-0)
Status: Failed on March 10 2018 - 100% progression
Action: 2018-03-10 - Died in Health Policy
Text: Latest bill text (Introduced) [HTML]

Summary

Requiring cancer clinical trial programs to inform prospective patient subjects of the specified reimbursements for ancillary costs and travel expenses which may be available to them and their caregivers if they participate in a cancer clinical trial; specifying that reimbursement offers may not be coercive or exert an undue influence and are not considered inducements for participation; requiring certain entities that offer reimbursement programs to secure the informed consent of patient subjects, etc.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Cancer Clinical Trials

Sponsors


History

DateChamberAction
2018-03-10SenateDied in Health Policy
2018-03-10SenateIndefinitely postponed and withdrawn from consideration
2018-01-17SenateIntroduced
2018-01-12SenateReferred to Health Policy; Appropriations Subcommittee on Health and Human Services; Appropriations; Rules
2017-12-28SenateFiled

Code Citations

ChapterArticleSectionCitation TypeStatute Text
3852021Amended CodeSee Bill Text

Florida State Sources


Bill Comments

feedback